Literature DB >> 21355942

Factors influencing the identification rate of the sentinel node in breast cancer.

D Gschwantler-Kaulich1, M Riegler-Keil, E Ruecklinger, C F Singer, M Seifert, E Kubista.   

Abstract

Sentinel node biopsy is a widely accepted alternative to primary axillary lymph node dissection for ipsilateral nodal assessment in breast cancer. We have performed a retrospective chart review in 713 consecutive patients with primary, operable breast cancer who underwent sentinel node biopsy in order to identify factors that determine the sentinel node identification rate. Chi-squared test, univariate and multivariate analyses were used to evaluate the influence of different factors on the sentinel identification rate. Among the factors investigated, tumour size was correlated with sentinel lymph nodes detection rates (multiple logistic regression, P= 0.002). In addition, the patient's age showed to be a significant influencing factor (multiple logistic regression, P= 0.006). Body mass index and grade only exhibited a significant correlation with the identification rate in the univariate (P= 0.041, P= 0.025), but not in the multivariate analysis (P= not significant). All associations were found to be independent of the site of injection. Interestingly, surgeons with intermediate expertise (11-20 prior dissections) had the highest detection rates (P= 0.004). We conclude that sentinel identification rates are higher in larger tumours and in younger patients, independent of the injection site. Surgical experience in sentinel node dissection is not linearly correlated with higher identification rates.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21355942     DOI: 10.1111/j.1365-2354.2011.01241.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  6 in total

1.  Pre-operative sentinel lymph node localization in breast cancer with superparamagnetic iron oxide MRI: the SentiMAG Multicentre Trial imaging subprotocol.

Authors:  Joost J Pouw; Maarten R Grootendorst; Roland Bezooijen; Caroline A H Klazen; Wieger I De Bruin; Joost M Klaase; Margaret A Hall-Craggs; Michael Douek; Bennie Ten Haken
Journal:  Br J Radiol       Date:  2015-10-22       Impact factor: 3.039

2.  Sentinel Lymph Node Biopsy in Early Breast Cancer Using Methylene Blue Dye Alone: a Safe, Simple, and Cost-Effective Procedure in Resource-Constrained Settings.

Authors:  Sreekar Devarakonda; Shawn Sam Thomas; Supriya Sen; Varghese Thomas; Reka Karuppusami; Anish Jacob Cherian; Pooja Ramakant; Deepak Thomas Abraham; Paul Mazhuvanchary Jacob
Journal:  Indian J Surg Oncol       Date:  2021-01-16

3.  Impact of Tumor Localization and Method of Preoperative Biopsy on Sentinel Lymph Node Mapping After Periareolar Nuclide Injection.

Authors:  Julia Krammer; Anja Dutschke; Clemens G Kaiser; Andreas Schnitzer; Axel Gerhardt; Julia C Radosa; Joachim Brade; Stefan O Schoenberg; Klaus Wasser
Journal:  PLoS One       Date:  2016-02-11       Impact factor: 3.240

4.  Contribution of SPECT/CT for sentinel node localization in patients with ipsilateral breast cancer relapse.

Authors:  Pablo Borrelli; Maarten L Donswijk; Marcel P Stokkel; Suzana C Teixeira; Harm van Tinteren; Emiel J Th Rutgers; Renato A Valdés Olmos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-10-27       Impact factor: 9.236

5.  The predictive value of methylene blue dye as a single technique in breast cancer sentinel node biopsy: a study from Dharmais Cancer Hospital.

Authors:  Bayu Brahma; Rizky Ifandriani Putri; Ramadhan Karsono; Bob Andinata; Walta Gautama; Lenny Sari; Samuel J Haryono
Journal:  World J Surg Oncol       Date:  2017-02-07       Impact factor: 2.754

6.  The application of methylene blue coloration technique in axillary lymph node dissection of breast cancer.

Authors:  Jieya Zou; Xiaoqi Wang; Zhuangqing Yang; Xiaojuan Yang; Chang'an Wang; Lifei Sun; Wenhuan Wang; Yue Wang; Jianyun Nie
Journal:  Transl Cancer Res       Date:  2019-12       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.